Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02217930 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers
A Phase 1 study, sponsored by Wockhardt.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT02217930: Completed Phase 1 study, sponsored by Wockhardt.
NCT02217930 is a Phase 1 study that has completed, run by Wockhardt. The registered enrollment target is 80 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02217930, a Phase 1 study, has completed, sponsored by Wockhardt.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
The study designed to determine the effect induced by WCK 2349 on the QT interval. The study will be conducted in two parts: 1) to determine the supratherapeutic dose; and 2) to assess the safety of high doses of single-dose administration of WCK 2349 on the QT interval.
Interventions
- DRUG Placebo
- DRUG Moxifloxacin
- DRUG WCK 2349
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-07 |
| Phase | Phase 1 |
What the finished NCT02217930 record still lists
NCT02217930 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% higher).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02217930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02217930 about?
NCT02217930 is a clinical study titled "Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers". The study designed to determine the effect induced by WCK 2349 on the QT interval. The study will be conducted in two parts: 1) to determine the supratherapeutic dose; and 2) to assess the safety of high doses of single-dose administration of WCK 2349 on the QT interval.
What is the current status of trial NCT02217930?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2014-08. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02217930?
The interventions under investigation include: Placebo (DRUG), Moxifloxacin (DRUG), WCK 2349 (DRUG).
Who is sponsoring clinical trial NCT02217930?
This trial is sponsored by Wockhardt, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02217930's enrollment target sits among peer trials
80 672nd of 2000 higher than 1,305 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia